These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27161659)

  • 1. The impact of insurance coverage and the family on pediatric diabetes management.
    Watson SE; Kuhl EA; Foster MB; Omoruyi AO; Kingery SE; Woods C; Wintergerst KA
    Pediatr Diabetes; 2017 Jun; 18(4):315-319. PubMed ID: 27161659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of health insurance coverage on pediatric diabetes management.
    Wintergerst KA; Hinkle KM; Barnes CN; Omoruyi AO; Foster MB
    Diabetes Res Clin Pract; 2010 Oct; 90(1):40-4. PubMed ID: 20630611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cohort of children with type 1 diabetes in Greece: predictors of direct costs of care.
    Karachaliou F; Athanasakis K; Tsentidis C; Soldatou A; Simatos G; Kyriopoulos J; Michalakos S; Karavanaki K
    Pediatr Diabetes; 2017 Aug; 18(5):405-412. PubMed ID: 27444352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of socio-economic and clinical factors on HbA1c in children and adolescents with type 1 diabetes: an Italian multicentre survey.
    Gesuita R; Skrami E; Bonfanti R; Cipriano P; Ferrito L; Frongia P; Iafusco D; Iannilli A; Lombardo F; Mozzillo E; Paleari R; Rabbone I; Sabbion A; Salvatoni A; Scaramuzza A; Schiaffini R; Sulli N; Toni S; Carle F; Cherubini V
    Pediatr Diabetes; 2017 May; 18(3):241-248. PubMed ID: 26990605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study.
    Abell SK; Suen M; Pease A; Boyle JA; Soldatos G; Regan J; Wallace EM; Teede HJ
    Diabetes Technol Ther; 2017 May; 19(5):280-287. PubMed ID: 28282241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous Subcutaneous Insulin Infusion During Pregnancy in Women with Complicated Type 1 Diabetes Is Associated with Better Glycemic Control but Not with Improvement in Pregnancy Outcomes.
    Kekäläinen P; Juuti M; Walle T; Laatikainen T
    Diabetes Technol Ther; 2016 Mar; 18(3):144-50. PubMed ID: 26502287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review.
    Roze S; Smith-Palmer J; Valentine W; de Portu S; Nørgaard K; Pickup JC
    Diabet Med; 2015 Nov; 32(11):1415-24. PubMed ID: 25962621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study.
    Sheikh K; Bartz SK; Lyons SK; DeSalvo DJ
    J Diabetes Res; 2018; 2018():5162162. PubMed ID: 30151393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Costs of Continuous Insulin Pump Therapy and Multiple Daily Injections for Type 1 Diabetes: A Population-Based and Propensity-Matched Cohort From the Swedish National Diabetes Register.
    Toresson Grip E; Svensson AM; Miftaraj M; Eliasson B; Franzén S; Gudbjörnsdottir S; Steen Carlsson K
    Diabetes Care; 2019 Apr; 42(4):545-552. PubMed ID: 30705062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study.
    Melidonis A; Kamaratos A; Angelidi A; Thomakos P; Vrakas S; Bakalis J; Fousteris E; Iraklianou S
    Diabetes Technol Ther; 2016 Mar; 18(3):159-63. PubMed ID: 26862678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment.
    Scott ES; McGrath RT; Januszewski AS; Calandro D; Hardikar AA; O'Neal DN; Fulcher G; Jenkins AJ
    BMJ Open; 2019 Dec; 9(12):e033059. PubMed ID: 31888933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion.
    Nixon R; Folwell R; Pickup JC
    Diabet Med; 2014 Oct; 31(10):1174-7. PubMed ID: 24804864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case-control study.
    Brorsson AL; Viklund G; Örtqvist E; Lindholm Olinder A
    Pediatr Diabetes; 2015 Nov; 16(7):546-53. PubMed ID: 25327782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada.
    St Charles ME; Sadri H; Minshall ME; Tunis SL
    Clin Ther; 2009 Mar; 31(3):657-67. PubMed ID: 19393856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German/Austrian DPV registry.
    Danne T; Schwandt A; Biester T; Heidtmann B; Rami-Merhar B; Haberland H; Müther S; Khodaverdi S; Haak T; Holl RW;
    Pediatr Diabetes; 2018 Aug; 19(5):979-984. PubMed ID: 29446511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey.
    Roze S; Smith-Palmer J; de Portu S; Özdemir Saltik AZ; Akgül T; Deyneli O
    Diabetes Technol Ther; 2019 Dec; 21(12):727-735. PubMed ID: 31509715
    [No Abstract]   [Full Text] [Related]  

  • 19. Intensive vs. conventional insulin management initiated at diagnosis in children with diabetes: should payer source influence the choice of therapy?
    Beck JK; Lewis TV; Logan KJ; Harrison DL; Gardner AW; Copeland KC
    Pediatr Diabetes; 2009 Sep; 10(6):368-73. PubMed ID: 19522746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
    Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
    Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.